Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, surveys show the percentage of US children reporting food allergies rose from 4.0% in 2007 to 6.5% in 2018.
Early evidence suggests stem cell therapy, including eye drops and exosomes, may improve dry eye symptoms in Sjögren's syndrome, but more research is needed before it becomes a…
A large meta-analysis found that having eczema (atopic dermatitis) in the first year of life is a strong risk factor for developing food allergy, with an odds ratio of 3.88.
A new 6-in-1 vaccine that includes protection against polio was licensed but was not available until at least 2021.
Reports describe poliovirus surveillance data from 40 high-risk countries, noting that Afghanistan, Pakistan, and Nigeria remain the only places with ongoing wild poliovirus…
Based on food challenge-confirmed studies, about 4.7% of children younger than 6 years have a food allergy, though other estimates range from 4.0% to 7.7% depending on the…
Polio transmission remains a risk in specific areas of Pakistan, conflict zones in Ethiopia, and regions in Africa and the Philippines affected by vaccine disruptions.
Yes, a once-daily bictegravir-lenacapavir single-tablet regimen is non-inferior to complex regimens for maintaining HIV-1 suppression at 48 weeks, based on phase 3 trial data.
Yes, maternal preeclampsia is linked to a modestly higher risk of neonatal sepsis in the first 28 days of life, based on a large meta-analysis.
Reducing unnecessary antibiotic use through antimicrobial stewardship strategies in newborns can lower both antibiotic exposure and mortality rates, especially in low-resource…
In low-income countries, severe RSV outcomes like hospitalization and death peak in infants between 2 and 5 months of age.
Nirsevimab is being rolled out for infants in New York City and is recommended for high-risk groups including those living with HIV or exposed to HIV.
Yes, valproate sodium injection is an approved intravenous alternative for complex partial seizures when a patient cannot take oral medication temporarily.
Limited evidence from systematic reviews suggests antibiotics may help some people with low back pain and Modic type 1 changes, but results are uncertain and more research is…
FDA approvals for valproic acid and related drugs explicitly cover both complex partial seizures and absence seizures, often allowing use for patients who have multiple seizure…
Yes, valproate sodium injection is FDA-approved for complex partial seizures when oral valproate is temporarily not feasible.
Yes, bariatric surgery significantly reduces low back pain in morbidly obese adults, with studies showing major improvements in pain scores and disability.
Yes, the FDA approved valproic acid oral solution for both monotherapy and adjunctive therapy to treat complex partial seizures.
A 2024 trial found that a sequenced care pathway was not superior to a pain navigator for Veterans with low back pain at 3 months.
About 48% of breast cancer patients experience chemotherapy-induced nausea and vomiting, with higher risk in younger patients and those with motion sickness history.
Yes, valproic acid oral solution is FDA-approved to be used alone for complex partial seizures.
5-HT3 antagonists and dexamethasone are both effective for CINV, but adding a 5-HT3 antagonist to dexamethasone improves outcomes; guidelines recommend using them together with…
Yes, photobiomodulation significantly reduces the risk of severe oral mucositis in head and neck cancer patients, with a 54% risk reduction shown in a recent meta-analysis.
Yes, Focinvez (fosaprepitant) is FDA-approved to prevent chemotherapy-induced nausea and vomiting when used with other antiemetics.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.